Wall Street Experts
ver. ZuMIgo(08/25)
Anavex Life Sciences Corp.
Rachunek Zysków i Strat
Przychody TTM (mln): 0
EBIT TTM (mln): -54
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
Rok finansowy |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Przychód Δ r/r |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Marża brutto |
0.0% |
-inf% |
-inf% |
-inf% |
-inf% |
0.0% |
-inf% |
-inf% |
0.0% |
-inf% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
EBIT (mln) |
-0 |
-0 |
-0 |
-2 |
-5 |
-5 |
-6 |
-6 |
-4 |
-2 |
-3 |
-7 |
-15 |
-16 |
-19 |
-29 |
-31 |
-42 |
-54 |
-47 |
0 |
EBIT Δ r/r |
0.0% |
532.8% |
-72.0% |
6065.9% |
234.0% |
-10.2% |
19.3% |
9.4% |
-30.1% |
-50.6% |
39.2% |
139.4% |
109.3% |
4.5% |
23.5% |
49.9% |
7.0% |
36.3% |
29.8% |
-12.7% |
-100.0% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
11 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
EBITDA (mln) |
-0 |
-0 |
-0 |
-2 |
-5 |
-4 |
-3 |
-5 |
-0 |
-2 |
-12 |
-12 |
-15 |
-16 |
-19 |
-29 |
-31 |
-42 |
-50 |
-47 |
0 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Podatek (mln) |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
1 |
4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-0 |
0 |
Zysk Netto (mln) |
-0 |
-0 |
-0 |
-2 |
-5 |
-5 |
-9 |
-7 |
-8 |
-4 |
-11 |
-12 |
-15 |
-13 |
-17 |
-26 |
-26 |
-38 |
-48 |
-47 |
-43 |
Zysk netto Δ r/r |
0.0% |
536.5% |
-72.1% |
6088.3% |
238.7% |
2.8% |
59.7% |
-16.8% |
13.6% |
-55.4% |
207.2% |
6.5% |
21.7% |
-8.7% |
29.7% |
50.7% |
-0.1% |
44.2% |
26.6% |
-1.0% |
-9.5% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
EPS |
-0.0075 |
-0.0211 |
-0.0053 |
-0.33 |
-1.09 |
-1.09 |
-1.64 |
-1.16 |
-1.18 |
-0.46 |
-1.16 |
-0.65 |
-0.42 |
-0.33 |
-0.39 |
-0.54 |
-0.45 |
-0.54 |
-0.62 |
-0.6 |
-0.52 |
EPS (rozwodnione) |
-0.0075 |
-0.0211 |
-0.0053 |
-0.33 |
-1.09 |
-1.09 |
-1.64 |
-1.16 |
-1.18 |
-0.46 |
-1.16 |
-0.65 |
-0.42 |
-0.33 |
-0.39 |
-0.54 |
-0.45 |
-0.54 |
-0.62 |
-0.6 |
-0.52 |
Ilośc akcji (mln) |
2 |
4 |
5 |
5 |
5 |
5 |
5 |
6 |
7 |
8 |
10 |
19 |
35 |
41 |
45 |
49 |
58 |
70 |
77 |
80 |
83 |
Ważona ilośc akcji (mln) |
2 |
4 |
5 |
5 |
5 |
5 |
5 |
6 |
7 |
8 |
10 |
19 |
35 |
41 |
45 |
49 |
58 |
70 |
77 |
80 |
83 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |